The function of brompheniramine is to inhibit cholinesterase activity, the main treatment of myasthenia gravis and so on.
Brompheniramine is a clinical anticholinesterase drug, usually patients take this drug, can effectively inhibit cholinesterase activity, promote nicotinic-like choline receptor excitation, but also can improve the gastrointestinal tract, bronchial smooth muscle muscle tone.
Therefore, brompheniramine is commonly used in clinical practice for the treatment of myasthenia gravis, functional intestinal flatulence and urinary retention after some surgeries, so as to alleviate patients’ discomfort and improve their quality of life.
Adverse reactions such as diarrhea, increased sweating, nausea and vomiting often occur in some patients after taking brompheniramine. As for some patients with myasthenia gravis, large doses of brompheniramine may cause mental abnormalities. Due to its efficacy factors, Brompyrazine is contraindicated in patients with angina pectoris, bronchial asthma, and urinary tract infarction to prevent aggravation of pre-existing conditions.
It is recommended to take Brompyrazine under the guidance of a doctor, and not to use the drug indiscriminately or increase or decrease the dose of the drug.